[开放获取]    湿疹皮炎类皮肤病中西医结合药物治疗专家共识

doi:10.35541/cjd.20220853

Abstract

Abstract: 【Abstract】 Eczema and dermatitis are very common diseases in dermatology. It is believed that they are dominant diseases for integrated traditional Chinese and Western medicine treatment, and many Western medicines and traditional Chinese medicines have been widely used in the treatment of these diseases. In order to ensure the rational application of these medicines, relevant experts developed this consensus on integrated traditional Chinese and Western medicine for eczema and dermatitis based on recent Chinese and international guidelines, consensus, and reported clinical studies, as well as personal clinical experience, aiming to standardize their application, improve efficacy and safety, and provide guidance for dermatologists in clinical practice.

Key words: Dermatitis, Eczema, Therapy, Integrated traditional Chinese and Western medicine, Chinese patent drugs, Consensus

Environmental and Occupational Skin Disease Research Group, Committee on Dermatology, Chinese Association of Integrative Medicine, Committee on Dermatology, Chinese Association of Geriatric Research, Committee on Dermatological Drug Research, The Chinese Association of Traditional Chinese Medicine. Expert consensus on integrated traditional Chinese and Western medicine for eczema and dermatitis[J]. Chinese Journal of Dermatology, 2023, 56(4): 287-293.doi:10.35541/cjd.20220853

References ［47］

［1］	中华医学会皮肤性病学分会免疫学组, 中国医师协会皮肤科医师分会指南制定与规范委员会. 皮炎湿疹类疾病规范化诊断术语专家共识［J］. 中华皮肤科杂志, 2021,54（11）:937⁃942. doi: 10.35541/cjd.20210578.
［2］	中国中西医结合学会皮肤性病专业委员会环境与职业性皮肤病学组, 中华医学会皮肤性病学分会儿童学组, 中国老年保健医学研究会皮肤科分会. 特应性皮炎外用制剂合理应用及患者指导专家共识［J］. 中华皮肤科杂志, 2022,55（4）:281⁃288. doi: 10.35541/cjd.20210833.
［3］	Boguniewicz M, Alexis AF, Beck LA, et al Expert perspectives on management of moderate⁃to⁃severe atopic dermatitis: a multidisciplinary consensus addressing current and emerging therapies［J］. J Allergy Clin Immunol Pract, 2017,5（6）:1519⁃1531. doi: 10.1016/j.jaip.2017.08.005.
［4］	Gooderham MJ, Bissonnette R, Grewal P, et al. Approach to the assessment and management of adult patients with atopic dermatitis: a consensus document. section II: tools for assessing the severity of atopic dermatitis［J］. J Cutan Med Surg, 2018,22（1_suppl）:10S⁃16S. doi: 10.1177/1203475418803628.
［5］	杜梦斐, 窦欣, 陈勇. 盐酸西替利嗪口服溶液联合除湿止痒洗液治疗小儿急性湿疹的临床疗效［J］. 中医临床研究, 2020,12（35）:107⁃109. doi: 10.3969/j.issn.1674⁃7860.2020.35.037.
［6］	白彦萍, 杨顶权, 王煜明, 等. 中药爽肤巾治疗急性湿疹的疗效观察［J］. 中国中西医结合杂志, 2007,27（1）:72⁃75. doi: 10.3321/j.issn:1003⁃5370.2007.01.017.
［7］	李红梅. 儿肤康搽剂治疗婴儿湿疹106例疗效分析［J］. 山东医药, 2005,45（27）:56. doi: 10.3969/j.issn.1002⁃266X.2005.27. 037.
［8］	赵淑英, 余嘉璇, 袁启航. 参柏洗液治疗皮炎湿疹的临床研究［J］. 中国新药杂志, 2020,29（5）:547⁃549. doi: 10.3969/j.issn. 1003⁃3734.2020.05.012.
［9］	中国中西医结合学会皮肤性病专业委员会环境与职业性皮肤病学组. 规范外用糖皮质激素类药物专家共识［J］. 中华皮肤科杂志, 2015,48（2）:73⁃75. doi: 10.3760/cma.j.issn.0412⁃4030.2015.02.001.
［10］	Faergemann J, Christensen O, Sjövall P, et al. An open study of efficacy and safety of long⁃term treatment with mometasone furoate fatty cream in the treatment of adult patients with atopic dermatitis［J］. J Eur Acad Dermatol Venereol, 2000,14（5）:393⁃396. doi: 10.1046/j.1468⁃3083.2000.00099.x.
［11］	Wollenberg A, Reitamo S, Atzori F, et al. Proactive treatment of atopic dermatitis in adults with 0.1% tacrolimus ointment［J］. Allergy, 2008,63（6）:742⁃750. doi: 10.1111/j.1398⁃9995.2008. 01683.x.
［12］	Papp K, Szepietowski JC, Kircik L, et al. Efficacy and safety of ruxolitinib cream for the treatment of atopic dermatitis: results from 2 phase 3, randomized, double⁃blind studies［J］. J Am Acad Dermatol, 2021,85（4）:863⁃872. doi: 10.1016/j.jaad.2021. 04.085.
［13］	Nakagawa H, Nemoto O, Igarashi A, et al. Delgocitinib ointment in pediatric patients with atopic dermatitis: a phase 3, randomized, double⁃blind, vehicle⁃controlled study and a subsequent open⁃label, long⁃term study［J］. J Am Acad Dermatol, 2021,85（4）:854⁃862. doi: 10.1016/j.jaad.2021.06.014.
［14］	李妍, 徐薇, 杨宝琦, 等. 青鹏软膏治疗儿童局限性湿疹的多中心随机对照研究［J］. 中华皮肤科杂志, 2017,50（6）:412⁃416. doi: 10.3760/cma.j.issn.0412⁃4030.2017.06.006.
［15］	申春平, 王榴慧, 王华, 等. 除湿止痒软膏治疗轻度婴儿期特应性皮炎的有效性及安全性多中心临床研究［J］. 中华皮肤科杂志, 2017,50（4）:279⁃282. doi: 10.3760/cma.j.issn.0412⁃4030.2017.04.010.
［16］	魏文国, 曾三武. 冰黄肤乐软膏治疗湿疹疗效观察［J］. 国际中医中药杂志, 2007,29（2）:120. doi: 10.3760/cma.j.issn.1673⁃4246.2007.02.020.
［17］	阮光洪. 复方甘草酸苷联合除湿止痒洗液治疗湿疹60例的疗效观察［J］. 中国实用医药, 2012,7（31）:178⁃179. doi: 10. 3969/j.issn.1673⁃7555.2012.31.138.
［18］	乌兰, 乌日娜, 斯琴. 中药皮肤康洗液治疗湿疹皮炎临床观察［J］. 内蒙古医学院学报, 2004,26（2）:116⁃117. doi: 10.3969/j.issn.1004⁃2113.2004.02.014.
［19］	李红梅. 儿肤康搽剂治疗婴儿湿疹106例疗效分析［J］. 山东医药, 2005,45（27）:56. doi: 10.3969/j.issn.1002⁃266X.2005.27. 037.
［20］	彭光辉, 张尚军, 王京生, 等. 青鹏软膏联合派瑞松乳膏治疗掌跖角化性湿疹临床观察［J］. 河北医药, 2011,33（20）:3178⁃3179. doi: 10.3969/j.issn.1002⁃7386.2011.20.082.
［21］	邓翠荣. 除湿止痒软膏治疗婴儿湿疹的临床观察［J］. 中国麻风皮肤病杂志, 2009,25（7）:555. doi: 10.3969/j.issn.1009⁃1157. 2009.07.046.
［22］	杜丹. 除湿止痒洗剂联合地奈德乳膏治疗湿疹的疗效［J］. 中国中西医结合皮肤性病学杂志, 2014,13（1）:31⁃32.
［23］	杨顶权, 白彦萍, 刘东玉. 中西医结合治疗女性手部湿疹的临床研究［J］. 北京中医药大学学报, 2005,28（1）:82⁃83. doi: 10.3321/j.issn:1006⁃2157.2005.01.025.
［24］	王建辉. 联合治疗小儿亚急性湿疹临床观察［J］. 现代中西医结合杂志, 2010,19（27）:3451⁃3452. doi: 10.3969/j.issn.1008⁃8849.2010.27.024.
［25］	路雪艳, 黄二顺, 谭燕红, 等. 青鹏软膏维持治疗对局限性湿疹预后的影响［J］. 中华皮肤科杂志, 2014,47（11）:810⁃811. doi: 10.3760/cma.j.issn.0412⁃4030.2014.011.013.
［26］	中国中西医结合学会皮肤性病专业委员会环境与职业性皮肤病学组. 抗组胺药在皮肤科应用专家共识［J］. 中华皮肤科杂志, 2017,50（6）:393⁃396. doi: 10.3760/cma.j.issn.0412⁃4030. 2017.06.001.
［27］	树叶, 刘向宇, 罗鸯鸯, 等. 白芍总苷治疗儿童特应性皮炎的临床疗效［J］. 中国医师杂志, 2021,23（12）:1881⁃1883. doi: 10.3760/cma.j.cn431274⁃20210409⁃00401.
［28］	杨长志, 钱齐宏, 朱婷婷, 等. 白芍总苷胶囊联合盐酸左西替利嗪片治疗皮炎湿疹的临床观察［J］. 临床和实验医学杂志, 2012,11（9）:701⁃702. doi: 10.3969/j.issn.1671⁃4695.2012.09.030.
［29］	中国医师协会皮肤科医师分会自身免疫病专业委员会. 环孢素治疗免疫相关性皮肤病专家建议［J］. 中华皮肤科杂志, 2022,55（6）:471⁃479. doi: 10.35541/cjd.20210434.
［30］	Levy LL, Urban J, King BA. Treatment of recalcitrant atopic dermatitis with the oral Janus kinase inhibitor tofacitinib citrate［J］. J Am Acad Dermatol, 2015,73（3）:395⁃399. doi: 10.1016/j.jaad.2015.06.045.
［31］	Simpson EL, Lacour JP, Spelman L, et al. Baricitinib in patients with moderate⁃to⁃severe atopic dermatitis and inadequate response to topical corticosteroids: results from two randomized monotherapy phase III trials［J］. Br J Dermatol, 2020,183（2）:242⁃255. doi: 10.1111/bjd.18898.
［32］	徐月英, 梁茂新, 刘进. 皮敏消胶囊治疗湿疹60例临床研究［J］. 辽宁医学杂志, 2002,16（1）:32. doi: 10.3969/j.issn.1001⁃1722.2002.01.019.
［33］	高晖, 陈敬, 李景云. 消风止痒颗粒治疗急性湿疹疗效观察［J］. 中国麻风皮肤病杂志, 2011,27（4）:239. doi: 10.3969/j.issn.1009⁃1157.2011.04.006.
［34］	张旭. 黄柏胶囊治疗湿疹60例［J］. 中医杂志, 2003,44（1）:57⁃57. doi: 10.3321/j.issn:1001⁃1668.2003.01.052.
［35］	赵婷, 刘瓦利, 吴萍, 等. 防风通圣颗粒治疗亚急性湿疹的随机、安慰剂对照研究［J］. 中国中药杂志, 2015,40（7）:1415⁃1418. doi: 10.4268/cjcmm20150737.
［36］	丛林. 皮敏消胶囊治疗慢性湿疹52例的临床疗效观察［J］. 临床医药文献电子杂志, 2020,7（37）:154⁃155.
［37］	桂凤淑, 华锦辉. 苦参片治疗湿疹76例疗效观察［J］. 临床和实验医学杂志, 2007,6（10）:151. doi: 10.3969/j.issn.1671⁃4695. 2007.10.128.
［38］	Mandelin JM, Rubins A, Remitz A, et al. Long⁃term efficacy and tolerability of tacrolimus 0.03% ointment in infants:* a two⁃year open⁃label study［J］. Int J Dermatol, 2012,51（1）:104⁃110. doi: 10.1111/j.1365⁃4632.2011.05015.x.
［39］	Sigurgeirsson B, Boznanski A, Todd G, et al. Safety and efficacy of pimecrolimus in atopic dermatitis: a 5⁃year randomized trial［J］. Pediatrics, 2015,135（4）:597⁃606. doi: 10.1542/peds.2014⁃1990.
［40］	Schlessinger J, Shepard JS, Gower R, et al. Safety, effectiveness, and pharmacokinetics of crisaborole in infants aged 3 to < 24 months with mild⁃to⁃moderate atopic dermatitis: a phase IV open⁃label study （CrisADe CARE 1）［J］. Am J Clin Dermatol, 2020,21（2）:275⁃284. doi: 10.1007/s40257⁃020⁃00510⁃6.
［41］	Simons FE, Silas P, Portnoy JM, et al. Safety of cetirizine in infants 6 to 11 months of age: a randomized, double⁃blind, placebo⁃controlled study［J］. J Allergy Clin Immunol, 2003,111（6）:1244⁃1248. doi: 10.1067/mai.2003.1496.
［42］	Hampel F, Ratner P, Haeusler JM. Safety and tolerability of levocetirizine dihydrochloride in infants and children with allergic rhinitis or chronic urticaria［J］. Allergy Asthma Proc, 2010,31（4）:290⁃295. doi: 10.2500/aap.2010.31.3349.
［43］	Gupta SK, Kantesaria B, Banfield C, et al. Desloratadine dose selection in children aged 6 months to 2 years: comparison of population pharmacokinetics between children and adults［J］. Br J Clin Pharmacol, 2007,64（2）:174⁃184. doi: 10.1111/j.1365⁃2125.2007.02859.x.
［44］	Paller AS, Siegfried EC, Simpson EL, et al. A phase 2, open⁃label study of single⁃dose dupilumab in children aged 6 months to <6 years with severe uncontrolled atopic dermatitis: pharmacokinetics, safety and efficacy［J］. J Eur Acad Dermatol Venereol, 2021,35（2）:464⁃475. doi: 10.1111/jdv.16928.
［45］	Silverberg JI, Simpson EL, Thyssen JP, et al. Efficacy and safety of abrocitinib in patients with moderate⁃to⁃severe atopic dermatitis: a randomized clinical trial［J］. JAMA Dermatol, 2020,156（8）:863⁃873. doi: 10.1001/jamadermatol.2020.1406.
［46］	Vestergaard C, Wollenberg A, Barbarot S, et al. European task force on atopic dermatitis position paper: treatment of parental atopic dermatitis during preconception, pregnancy and lactation period［J］. J Eur Acad Dermatol Venereol, 2019,33（9）:1644⁃1659. doi: 10.1111/jdv.15709.
［47］	中国中西医结合学会皮肤性病专业委员会环境与职业性皮肤病学组, 中国老年保健医学研究会皮肤科分会. 系统Janus激酶抑制剂治疗特应性皮炎专家共识［J］. 实用皮肤病学杂志, 2022,15（3）:129⁃135. doi: 10.11786/sypfbxzz.1674⁃1293. 20220301.

[1]	Jiang Xiaoyan, Gao Min, Zhang Xiaoyan, Liu Ningyuan. Interleukin-17 and interleukin-23 inhibitors in the treatment of pustular psoriasis [J]. Chinese Journal of Dermatology, 2023, 56(7): 689-692.
[2]	Li Yue, Wu Jinyan, Yuan Ruoyue, Yang Quyang, Zhao Xiansheng, Zhu Ningwen. Cell therapy for hereditary epidermolysis bullosa [J]. Chinese Journal of Dermatology, 2023, 56(7): 698-702.
[3]	Qu Litian, Chen Jincong, Cheng Bo, Su Huichun, . Correlations of transglutaminase 2 expression in peripheral blood mononuclear cells with relevant inflammatory factors and disease severity in patients with atopic dermatitis [J]. Chinese Journal of Dermatology, 2023, 56(7): 651-656.
[4]	Su Chang, Sui Xiuli, Liu Ruiling, Cao Yiqun, Jiang Hong, Yan Cairong, Wang Huiping, Qi Yuqing. Omalizumab for the treatment of 74 patients with chronic spontaneous urticaria accompanied by other allergic diseases: a clinical analysis [J]. Chinese Journal of Dermatology, 2023, 56(6): 512-517.
[5]	Chen Qiquan, Yang Xianjie, Gu Heng, Xu Jinhua, Hao Fei, Yao Xu, Song Zhiqiang. Construction of “Expert consensus on diagnosis and treatment of chronic inducible urticaria in China （2023）” based on the Delphi method [J]. Chinese Journal of Dermatology, 2023, 56(6): 534-539.
[6]	Immunology Group, Chinese Society of Dermatology. Expert consensus on diagnosis and treatment of chronic inducible urticaria in China （2023） [J]. Chinese Journal of Dermatology, 2023, 56(6): 479-488.
[7]	Chinese Society of Dermatology, China Dermatologist Association. Expert consensus on treat-to-target in chronic spontaneous urticaria （2023） [J]. Chinese Journal of Dermatology, 2023, 56(6): 489-495.
[8]	Wei Jin, Yan Huiwen, Zhao Tianwei, Ran Liwei, Lun Wenhui, Zhang Jianzhong. Eczematoid clear cell acanthoma of the nipple/areola: the first case reported in China and literature analysis [J]. Chinese Journal of Dermatology, 2023, 56(6): 545-548.
[9]	Ren Fenfen, Wang Peng, Zhang Jingzhan, Kang Xiaojing. Network pharmacology-based prediction of potential effective components of traditional Chinese medicine and their molecular mechanisms of action in the anti-angiogenic treatment of Kaposi′s sarcoma [J]. Chinese Journal of Dermatology, 2023, 56(5): 428-433.
[10]	Writing Committee Expert Group on “Treatment of mycosis fungoides: a Chinese expert consensus （）”. Treatment of mycosis fungoides: a Chinese expert consensus （2023） [J]. Chinese Journal of Dermatology, 2023, 56(5): 402-409.
[11]	Jin Shiying, Shi Jinjun, Gao Qi, Chen Mei, Dong Zhengbang, Yan Qiao, Li Jijian, Wang Fei. High-frequency ultrasonography-assisted evaluation of treatment outcomes of erysipelas: a prospective controlled study [J]. Chinese Journal of Dermatology, 2023, 56(5): 434-438.
[12]	Li Rong, Zhang Jiaan, Chen Kun. Photoelectric therapy for rosacea [J]. Chinese Journal of Dermatology, 2023, 56(5): 468-470.
[13]	Jia Weixue, Li Chengrang. Comparison of Chinese and international guidelines and consensus for the diagnosis and treatment of vitiligo [J]. Chinese Journal of Dermatology, 2023, 56(5): 471-475.
[14]	Li Jiaqi, Ye Feng, Ju Qiang. Symbiotic homeostasis of Staphylococcus epidermidis is associated with common skin disorders [J]. Chinese Journal of Dermatology, 2023, 56(5): 459-462.
[15]	Jin Liping, Zhu Wu, Lu Yan, Liu Panpan, Tan Minjia, Wang Ying, Yang Jing, Xu Licong, Hu Kun, Kuang Yehong. Dietary intervention for the treatment of psoriasis [J]. Chinese Journal of Dermatology, 2023, 56(4): 357-360.

Expert consensus on integrated traditional Chinese and Western medicine for eczema and dermatitis

PDF

Knowledge

Abstract

Cite this article

share this article

References ［47］

Related Articles 15

Metrics

Comments

Recommended 10